Mike Fraser

Mike Fraser is a seasoned professional with over 20 years of experience in the pharmaceutical industry, specializing in strategy, analytics, digital innovation, early drug development, brand launches, and brand management.

Currently serving as the General Manager for Europe, Middle East, and Africa at Novartis Gene Therapies, Mike leads a multinational team dedicated to introducing cutting-edge gene therapies to market to benefit those affected by rare genetic diseases.

Throughout his tenure at Novartis, Mike has excelled in various leadership roles, spearheading teams at regional and global levels across different product life cycle stages and therapeutic areas. His expertise extends to successfully managing in-line brands and driving forward-looking initiatives.

Mike's background includes pivotal positions such as General Manager Europe, Middle East, and Africa at AveXis, Inc., Vice President of Strategy and Innovation at Sandoz, and leadership roles in strategic insights, analytics, new product planning, commercialization, and brand management at Novartis.

His educational foundation includes studies at the University of South Africa/Universiteit van Suid-Afrika, complementing his extensive practical experience in the field.